Sodium Iodide [131I] Injection GE Healthcare 925 MBq/ ml Norveġja - Norveġiż - Statens legemiddelverk

sodium iodide [131i] injection ge healthcare 925 mbq/ ml

ge healthcare buchler gmbh & co. kg - natriumjodid (131i) - injeksjonsvæske, oppløsning - 925 mbq/ ml

Sodium Iodide [131I] Injection GE Healthcare 74 MBq/ ml Norveġja - Norveġiż - Statens legemiddelverk

sodium iodide [131i] injection ge healthcare 74 mbq/ ml

ge healthcare buchler gmbh & co. kg - natriumjodid (131i) - injeksjonsvæske, oppløsning - 74 mbq/ ml

TechneScan LyoMAA - Norveġja - Norveġiż - Statens legemiddelverk

technescan lyomaa -

curium netherlands b.v. - albumin humant serum makroaggregater ad tc-99m makroalbumin - pulver til injeksjonsvæske, oppløsning

TechneScan MAG3 1 mg Norveġja - Norveġiż - Statens legemiddelverk

technescan mag3 1 mg

curium netherlands b.v. - betiatid - preparasjonssett til radioaktive legemidler - 1 mg

TechneScan PYP 20 mg Norveġja - Norveġiż - Statens legemiddelverk

technescan pyp 20 mg

curium netherlands b.v. - natriumpyrofosfat - preparasjonssett til radioaktive legemidler - 20 mg

TechneScan DTPA - Norveġja - Norveġiż - Statens legemiddelverk

technescan dtpa -

curium netherlands b.v. - kalsiumtrinatriumpentetat - preparasjonssett til radioaktive legemidler

Venticoll 0.5 mg Norveġja - Norveġiż - Statens legemiddelverk

venticoll 0.5 mg

ge healthcare as - albumin, humant, kolloidale partikler - pulver til inhalasjonsvæske til nebulisator, oppløsning - 0.5 mg

Arsenic trioxide medac Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

arsenic trioxide medac

medac gesellschaft für klinische spezialpräparate mbh - arsen trioxide - leukemi, promyelocytisk, akutt - antineoplastiske midler - arsenic trioxide medac is indicated for induction of remission, and consolidation in adult patients with:newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 10³/μl) in combination with all-trans-retinoic acid (atra)relapsed/refractory apl (previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rarα) gene. svarprosenten av andre akutt myelogen leukemi undertyper å arsen trioxide har ikke vært undersøkt.

Tolterodine Sandoz 4 mg Norveġja - Norveġiż - Statens legemiddelverk

tolterodine sandoz 4 mg

sandoz - københavn - tolterodintartrat - depotkapsel, hard - 4 mg

Tolterodine Sandoz 2 mg Norveġja - Norveġiż - Statens legemiddelverk

tolterodine sandoz 2 mg

sandoz - københavn - tolterodintartrat - depotkapsel, hard - 2 mg